Remus Pharmaceuticals (REMUS)

Volume: 3,800Avg Vol 1W: 5,980Avg Vol 1M: 5,93552W Range:₹580₹1,021.8

₹754▼ 2.58%

Key Ratios

Market Cap—

Current Price₹754

Previous Close₹774

High / Low (52w)₹1,021.8 / ₹580

Volume3,800

Avg Vol (1W)5,980

Avg Vol (1M)5,935

Stock P/E11.56

Book Value₹434.4

Dividend Yield—

ROE—

ROA—

Revenue (TTM)₹625 Cr

Revenue Growth191.3%

Profit Margin—

Total Debt₹3 Cr

Shares Outstanding—

Face Value—

EPS (TTM)₹65.23

P/B—

Debt / Equity—

50 DMA₹653.81

200 DMA₹739.86

Day change-2.58%

Price Chart

₹754▼ 19.02% · 1Y

2025-06-17

2026-05-11

20-day avg volume: 6K shares

Cons

Profit & Loss (Annual)

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Revenue	₹13 Cr	₹19 Cr	₹25 Cr	₹47 Cr	₹216 Cr	₹625 Cr
EBITDA	₹1 Cr	₹1 Cr	₹5 Cr	₹12 Cr	₹31 Cr	₹49 Cr
Net Profit	₹1 Cr	₹1 Cr	₹3 Cr	₹9 Cr	₹21 Cr	₹29 Cr
EPS	—	—	—	—	—	—

Balance Sheet

Metric	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Assets	₹5 Cr	₹11 Cr	₹16 Cr	₹35 Cr	₹333 Cr	₹433 Cr
Total Liabilities	₹3 Cr	₹8 Cr	₹9 Cr	₹16 Cr	₹158 Cr	₹150 Cr
Equity	₹2 Cr	₹3 Cr	₹7 Cr	₹19 Cr	₹175 Cr	₹283 Cr
Total Debt	₹0 Cr	₹0 Cr	₹0 Cr	₹7 Cr	₹3 Cr	₹3 Cr

Cash Flow

Metric	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Operating	₹0 Cr	₹6 Cr	₹8 Cr	₹7 Cr	₹14 Cr
Investing	₹0 Cr	₹-5 Cr	₹-15 Cr	₹-30 Cr	₹-11 Cr
Financing	₹0 Cr	₹0 Cr	₹12 Cr	₹28 Cr	₹6 Cr
Free Cash Flow	₹0 Cr	₹6 Cr	₹8 Cr	₹7 Cr	₹14 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search